Laurent Brard

4.5k total citations
85 papers, 3.7k citations indexed

About

Laurent Brard is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Laurent Brard has authored 85 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 30 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Laurent Brard's work include Fullerene Chemistry and Applications (15 papers), Ovarian cancer diagnosis and treatment (10 papers) and Cell death mechanisms and regulation (9 papers). Laurent Brard is often cited by papers focused on Fullerene Chemistry and Applications (15 papers), Ovarian cancer diagnosis and treatment (10 papers) and Cell death mechanisms and regulation (9 papers). Laurent Brard collaborates with scholars based in United States, Canada and United Kingdom. Laurent Brard's co-authors include Tobin J. Marks, Michael A. Giardello, Vincent P. Conticello, Robert M. Strongin, Ajay Singh, Michel R. Gagné, Amos B. Smith, C.O. Granai, Narasimha Swamy and Yanwu Li and has published in prestigious journals such as Journal of the American Chemical Society, Physical Review Letters and Journal of Clinical Oncology.

In The Last Decade

Laurent Brard

84 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurent Brard United States 34 1.9k 803 769 604 535 85 3.7k
Dan Su China 33 891 0.5× 1.4k 1.7× 613 0.8× 791 1.3× 174 0.3× 100 4.0k
Makoto Yasuda Japan 42 4.5k 2.4× 1.2k 1.5× 1.2k 1.6× 548 0.9× 543 1.0× 324 7.3k
Shoji Hara Japan 40 2.7k 1.4× 1.0k 1.3× 645 0.8× 266 0.4× 371 0.7× 358 5.7k
Michael Watkinson United Kingdom 37 1.6k 0.8× 1.1k 1.3× 818 1.1× 1.2k 2.0× 590 1.1× 139 4.9k
Yoshito Takeuchi Japan 28 1.1k 0.6× 538 0.7× 301 0.4× 360 0.6× 298 0.6× 243 3.1k
José Pérez Spain 32 1.6k 0.9× 613 0.8× 737 1.0× 442 0.7× 1.4k 2.5× 165 3.4k
James D. Hoeschele United States 27 1.3k 0.7× 833 1.0× 443 0.6× 460 0.8× 1.9k 3.6× 65 2.9k
Tsugio Kitamura Japan 44 6.9k 3.6× 476 0.6× 1.5k 2.0× 712 1.2× 543 1.0× 262 9.4k
Christophe Dugave France 24 847 0.4× 1.3k 1.6× 376 0.5× 376 0.6× 247 0.5× 60 3.2k
Hiroto Yoshida Japan 52 5.9k 3.1× 821 1.0× 556 0.7× 269 0.4× 477 0.9× 174 7.8k

Countries citing papers authored by Laurent Brard

Since Specialization
Citations

This map shows the geographic impact of Laurent Brard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Brard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Brard more than expected).

Fields of papers citing papers by Laurent Brard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Brard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Brard. The network helps show where Laurent Brard may publish in the future.

Co-authorship network of co-authors of Laurent Brard

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Brard. A scholar is included among the top collaborators of Laurent Brard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Brard. Laurent Brard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, Elizabeth M., Sarah C. Nelson, Kathleen Groesch, et al.. (2024). Potential tools for predicting response to chemotherapy in OC: Assessment of immune dysbiosis, participant’s self-rated health and microbial dynamics. Journal of Reproductive Immunology. 163. 104241–104241. 1 indexed citations
2.
Li, Miao, Paula Díaz‐Sylvester, Kathleen Groesch, et al.. (2023). Evaluation of sterol‑o‑acyl transferase 1 and cholesterol ester levels in plasma, peritoneal fluid and tumor tissue of patients with endometrial cancer: A pilot study. Oncology Letters. 25(6). 231–231. 4 indexed citations
3.
Zahnd, Whitney E., Aimee S. James, Wiley D. Jenkins, et al.. (2017). Rural–Urban Differences in Cancer Incidence and Trends in the United States. Cancer Epidemiology Biomarkers & Prevention. 27(11). 1265–1274. 313 indexed citations
4.
Hsieh, Tsung‐Han, et al.. (2017). Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines. BMC Cancer. 17(1). 49–49. 26 indexed citations
5.
Alanee, Shaheen, Kristin Delfino, Andrew Wilber, et al.. (2017). Single nucleotide variant in Nucleoporin 107 may be predictive of sensitivity to chemotherapy in patients with ovarian cancer. Pharmacogenetics and Genomics. 27(7). 264–269. 13 indexed citations
6.
Brard, Laurent, et al.. (2014). Bithionol inhibits ovarian cancer cell growth In Vitro- studies on mechanism(s) of action. BMC Cancer. 14(1). 61–61. 42 indexed citations
7.
Brodsky, Alexander S., Andrew Fischer, Daniel Miller, et al.. (2014). Expression Profiling of Primary and Metastatic Ovarian Tumors Reveals Differences Indicative of Aggressive Disease. PLoS ONE. 9(4). e94476–e94476. 52 indexed citations
8.
Wu, Hsin-Ta, Andrew Fischer, Daniel Miller, et al.. (2013). Identification of Ovarian Cancer Metastatic miRNAs. PLoS ONE. 8(3). e58226–e58226. 77 indexed citations
9.
Yoshioka, Shin, Mandy L. King, Sophia Ran, et al.. (2012). WNT7A Regulates Tumor Growth and Progression in Ovarian Cancer through the WNT/β-Catenin Pathway. Molecular Cancer Research. 10(3). 469–482. 141 indexed citations
10.
Kim, Kyu Kwang, Thilo S. Lange, Ajay Singh, Laurent Brard, & Richard G. Moore. (2012). Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C. BMC Cancer. 12(1). 147–147. 35 indexed citations
11.
Miller, Daniel, Andrew Fischer, Katrina F. Chu, et al.. (2011). T090137 Inhibits Cisplatin-Induced Apoptosis in Ovarian Cancer Cells. International Journal of Gynecological Cancer. 21(8). 1350–1356. 7 indexed citations
12.
Kim, Kyu Kwang, Thilo S. Lange, Ajay Singh, & Laurent Brard. (2010). Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells. BMC Cancer. 10(1). 72–72. 15 indexed citations
13.
Singh, Ajay, Kyu Kwang Kim, Roger D. Nussbaum, et al.. (2009). Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum‐resistant ovarian cancer cells to paraplatin. Phytotherapy Research. 23(8). 1066–1074. 55 indexed citations
14.
McCourt, Carolyn K., et al.. (2009). Is There a Taxane-Free Interval That Predicts Response to Taxanes as a Later-Line Treatment of Recurrent Ovarian or Primary Peritoneal Cancer?. International Journal of Gynecological Cancer. 19(3). 343–347. 3 indexed citations
15.
Sholler, Giselle L. Saulnier, Laurent Brard, Satyan Kalkunte, et al.. (2009). Nifurtimox Induces Apoptosis of Neuroblastoma Cells In Vitro and In Vivo. Journal of Pediatric Hematology/Oncology. 31(3). 187–193. 35 indexed citations
16.
Singh, Ajay, Thilo S. Lange, Kyu Kwang Kim, & Laurent Brard. (2009). A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. Investigational New Drugs. 29(1). 63–72. 48 indexed citations
17.
Singh, Ajay, Thilo S. Lange, Kyu Kwang Kim, Sunil K. Shaw, & Laurent Brard. (2008). A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells. Gynecologic Oncology. 109(2). 240–249. 16 indexed citations
18.
Singh, Ajay, et al.. (2008). Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells. British Journal of Cancer. 99(11). 1823–1831. 11 indexed citations
19.
Schwartz, Joseph E., Allan Bradley, Laurent Brard, et al.. (2006). Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital. Gynecologic Oncology. 105(1). 81–83. 56 indexed citations
20.
Giardello, Michael A., Vincent P. Conticello, Laurent Brard, Michel R. Gagné, & Tobin J. Marks. (1994). Chiral Organolanthanides Designed for Asymmetric Catalysis. A Kinetic and Mechanistic Study of Enantioselective Olefin Hydroamination/Cyclization and Hydrogenation by C1-Symmetric Me2Si(Me4C5)(C5H3R*)Ln Complexes where R* = Chiral Auxiliary. Journal of the American Chemical Society. 116(22). 10241–10254. 280 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dan Su Breakdown of academic impact, for papers by Makoto Yasuda Breakdown of academic impact, for papers by Shoji Hara Breakdown of academic impact, for papers by Michael Watkinson Breakdown of academic impact, for papers by Yoshito Takeuchi Breakdown of academic impact, for papers by José Pérez Breakdown of academic impact, for papers by James D. Hoeschele Breakdown of academic impact, for papers by Tsugio Kitamura Breakdown of academic impact, for papers by Christophe Dugave Breakdown of academic impact, for papers by Hiroto Yoshida
Rankless by CCL
2026